Bank of Ann Arbor’s Amgen AMGN Stock Holding History

Bank of Ann Arbor’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$201K	Buy	+476	New	+$190K	0.03%	196

Other funds holding AMGN

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Bank of Ann Arbor's AMGN Position: Q3 2026 in Review

Bank of Ann Arbor opened a new position in Amgen (AMGN) in Q3 2026: 476 shares worth $201K. The stake represents 0.03% of the portfolio and ranks #196 among its holdings.

2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Bank of Ann Arbor held 476 shares of Amgen worth $201K as of Q3 2026.
Amgen was a new Bank of Ann Arbor position in Q3 2026.
Amgen made up 0.03% of Bank of Ann Arbor's portfolio in Q3 2026, its #196 holding.
2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Bank of Ann Arbor's 13F filing for Q3 2026, filed 13 Nov 2026.